These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9542500)

  • 1. Lipids, the cardiovascular system and HRT.
    S Afr Med J; 1998 Feb; 88 Suppl 1():C52. PubMed ID: 9542500
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk].
    Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
    Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy (HRT) for hyperlipidemia after menopause].
    Sakuma I; Kitabatake A
    Nihon Rinsho; 2002 May; 60(5):1025-31. PubMed ID: 12029981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal treatment of postmenopausal women.
    Belchetz PE
    N Engl J Med; 1994 Apr; 330(15):1062-71. PubMed ID: 8127335
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in hormone replacement therapy.
    Smith RN; Studd JW
    Br J Hosp Med; 1993 Jun 2-15; 49(11):799-808. PubMed ID: 8334484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are changes in lipoproteins during HRT important?
    Stevenson JC
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():39-43; discussion 43-4. PubMed ID: 8624341
    [No Abstract]   [Full Text] [Related]  

  • 8. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.
    Hippisley-Cox J; Pringle M; Crown N; Coupland C
    Br J Gen Pract; 2003 Mar; 53(488):191-6. PubMed ID: 14694694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy and risk of ischemic heart disease and other causes of death. A review of studies published 1970-1992].
    Eiken PA
    Ugeskr Laeger; 1993 Dec; 155(50):4067-76. PubMed ID: 8273224
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effectiveness of estrogen replacement therapy to reduce ischemic heart disease--revaluation].
    Ben-Chetrit A; Zacut D; Shimonovitz S
    Harefuah; 2003 Jan; 142(1):32-7, 78. PubMed ID: 12647487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should women with diabetes mellitus receive hormone replacement therapy?
    Dunne FP
    Int J Clin Pract; 1997; 51(5):299-303. PubMed ID: 9489089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postmenopausal estrogen replacement therapy--does it reduce morbidity and mortality from ischemic heart disease?].
    Zyssman I; Schlezinger Z
    Harefuah; 1996 Feb; 130(3):200-3. PubMed ID: 8682400
    [No Abstract]   [Full Text] [Related]  

  • 15. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Menopause in women and cardiovascular diseases].
    Sakuma I; Kitabatake A
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1690-4. PubMed ID: 14560603
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmenopausal hormone replacement therapy with low-dose medroxyprogesterone acetate. Endometrium, plasma lipids, lipoproteins and apolipoproteins.
    Castelo-Branco C; Casals E; Sanllehy C; Fortuny A; Vanrell JA; González-Merlo J
    J Reprod Med; 1995 Apr; 40(4):305-11. PubMed ID: 7623361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy.
    Stauffer BL; Hoetzer GL; Smith DT; DeSouza CA
    J Appl Physiol (1985); 2004 Jan; 96(1):143-8. PubMed ID: 12949021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequentially combined estradiol valerate plus levonorgestrel therapy decreases 18:1 trans-fatty acid content of plasma lipids in healthy postmenopausal women.
    Jokela H; Kalela A; Lilja M; Salmi M; Lehtimäki T; Kunnas T; Teisala K; Punnonen R; Nikkari ST
    Gynecol Endocrinol; 2005 Dec; 21(6):360-5. PubMed ID: 16390785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.